β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 5, 2011, Pages 781-789

  Fajardo, Giovanni ^a   Zhao, Mingming ^a   Berry, Gerald ^b   Wong, Lee Jun ^c   Mochly Rosen, Daria ^a   Bernstein, Daniel ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adrenergic receptors; Cardiomyopathy; Mitochondria; Protein kinases; Signal transduction

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CALCIUM ION; CYCLOSPORIN; DOXORUBICIN; PRAZOSIN; PROTEIN KINASE B; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); TACROLIMUS; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOTOXICITY; CELL DEATH; CELL SURFACE; CONTROLLED STUDY; DRUG POTENTIATION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART PROTECTION; MALE; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL PERMEABILITY; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANIMALS; APOPTOSIS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CARDIOMYOPATHIES; CYCLOSPORINE; DOXORUBICIN; ENZYME INHIBITORS; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PRAZOSIN; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; SURVIVAL RATE; VERAPAMIL;

MUS;

EID: 80053221896     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.06.019     Document Type: Article

References (54)

1. Communal C., Singh K., Pimentel D.R., Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 1998, 98:1329-1334.
2. Zhu W.Z., Wang S.Q., Chakir K., Yang D., Zhang T., Brown J.H., et al. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest 2003, 111:617-625.
3. Chesley A., Lundberg M.S., Asai T., Xiao R.P., Ohtani S., Lakatta E.G., et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase. Circ Res 2000, 87:1172-1179.
4. Shenoy S.K., Drake M.T., Nelson C.D., Houtz D.A., Xiao K., Madabushi S., et al. Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 2006, 281:1261-1273.
5. Fajardo G., Zhao M., Powers J., Bernstein D. Differential cardiotoxic/cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy. J Mol Cell Cardiol 2006, 40:375-383.
6. Bernstein D., Fajardo G., Zhao M., Urashima T., Powers J., Berry G., et al. Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol 2005, 289:H2441-H2449.
7. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci USA 2001, 98:11114-11119.
8. Chen C., Mochly-Rosen D. Opposing effects of delta and xi PKC in ethanol-induced cardioprotection. J Mol Cell Cardiol 2001, 33:581-585.
9. Kabir A.M., Clark J.E., Tanno M., Cao X., Hothersall J.S., Dashnyam S., et al. Cardioprotection initiated by reactive oxygen species is dependent on activation of PKCepsilon. Am J Physiol Heart Circ Physiol 2006, 291:H1893-H1899.
10. Kim M.Y., Kim M.J., Yoon I.S., Ahn J.H., Lee S.H., Baik E.J., et al. Diazoxide acts more as a PKC-epsilon activator, and indirectly activates the mitochondrial K(ATP) channel conferring cardioprotection against hypoxic injury. Br J Pharmacol 2006, 149:1059-1070.
11. Matsui T., Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 2005, 38:63-71.
12. Hausenloy D.J., Yellon D.M. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 2006, 70:240-253.
13. Negoro S., Oh H., Tone E., Kunisada K., Fujio Y., Walsh K., et al. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation 2001, 103:555-561.
14. Taniyama Y., Walsh K. Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth. J Mol Cell Cardiol 2002, 34:1241-1247.
15. Xiang P., Deng H.Y., Li K., Huang G.Y., Chen Y., Tu L., et al. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Cancer Chemother Pharmacol 2009, 63:343-349.
16. Gustafsson A.B., Gottlieb R.A. Heart mitochondria: gates of life and death. Cardiovasc Res 2008, 77:334-343.
17. Wallace K.B. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol 2003, 93:105-115.
18. Olson L.E., Bedja D., Alvey S.J., Cardounel A.J., Gabrielson K.L., Reeves R.H. Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1. Cancer Res 2003, 63:6602-6606.
19. Mukhopadhyay P., Rajesh M., Batkai S., Kashiwaya Y., Hasko G., Liaudet L., et al. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 2009, 296:H1466-H1483.
20. Chan K.K., Cohen J.L., Gross J.F., Himmelstein K.J., Bateman J.R., Tsu-Lee Y., et al. Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. Cancer Treat Rep 1978, 62:1161-1171.
21. Donelli M.G., Martini A., Colombo T., Bossi A., Garattini S. Heart levels of adriamycin in normal and tumor-bearing mice. Eur J Cancer 1976, 12:913-923.
22. Inagaki K., Mochly-Rosen D. DeltaPKC-mediated activation of epsilonPKC in ethanol-induced cardiac protection from ischemia. J Mol Cell Cardiol 2005, 39:203-211.
23. Yu S.M., Hsu S.Y., Ko F.N., Chen C.C., Huang Y.L., Huang T.F., et al. Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Pharmacol 1992, 106:797-801.
24. Sridhar R., Dwivedi C., Anderson J., Baker P.B., Sharma H.M., Desai P., et al. Effects of verapamil on the acute toxicity of doxorubicin in vivo. J Natl Cancer Inst 1992, 84:1653-1660.
25. Friberg H., Ferrand-Drake M., Bengtsson F., Halestrap A.P., Wieloch T. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci 1998, 18:5151-5159.
26. Santos J.B., Schauwecker P.E. Protection provided by cyclosporin A against excitotoxic neuronal death is genotype dependent. Epilepsia 2003, 44:995-1002.
27. Johnson J.A., Mochly-Rosen D. Inhibition of the spontaneous rate of contraction of neonatal cardiac myocytes by protein kinase C isozymes. A putative role for the epsilon isozyme. Circ Res 1995, 76:654-663.
28. Brautbar A., Wang J., Abdenur J.E., Chang R.C., Thomas J.A., Grebe T.A., et al. The mitochondrial 13513G>A mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscle. Mol Genet Metab 2008, 94:485-490.
29. O'Connell T.D., Rodrigo M.C., Simpson P.C. Isolation and culture of adult mouse cardiac myocytes. Methods Mol Biol 2007, 357:271-296.
30. Zhou Y.Y., Wang S.Q., Zhu W.Z., Chruscinski A., Kobilka B.K., Ziman B., et al. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am J Physiol Heart Circ Physiol 2000, 279:H429-H436.
31. Silver R.B. Ratio imaging: measuring intracellular Ca++ and pH in living cells. Methods Cell Biol 2003, 72:369-387.
32. Nagata K., Liao R., Eberli F.R., Satoh N., Chevalier B., Apstein C.S., et al. Early changes in excitation-contraction coupling: transition from compensated hypertrophy to failure in Dahl salt-sensitive rat myocytes. Cardiovasc Res 1998, 37:467-477.
33. Ballou L.M., Tian P.Y., Lin H.Y., Jiang Y.P., Lin R.Z. Dual regulation of glycogen synthase kinase-3beta by the alpha1A-adrenergic receptor. J Biol Chem 2001, 276:40910-40916.
34. Ballou L.M., Lin H.Y., Fan G., Jiang Y.P., Lin R.Z. Activated G alpha q inhibits p110 alpha phosphatidylinositol 3-kinase and Akt. J Biol Chem 2003, 278:23472-23479.
35. Zhou S., Starkov A., Froberg M.K., Leino R.L., Wallace K.B. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res 2001, 61:771-777.
36. Xiao R.P. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Sci STKE 2001, 2001:RE15.
37. Chruscinski A.J., Rohrer D.K., Schauble E., Desai K.H., Bernstein D., Kobilka B.K. Targeted disruption of the beta2 adrenergic receptor gene. J Biol Chem 1999, 274:16694-16700.
38. Zhang G.X., Kimura S., Murao K., Obata K., Matsuyoshi H., Takaki M. Inhibition of cytochrome c release by 10-N-nonyl acridine orange, a cardiolipin-specific dye, during myocardial ischemia-reperfusion in the rat. Am J Physiol Heart Circ Physiol 2010, 298:H433-H439.
39. Fajardo G., Bernstein D. Endocannabinoid inhibition: a new cardioprotective strategy against doxorubicin cardiotoxicity. J Am Coll Cardiol 2007, 50:537-539.
40. Gregory K.N., Hahn H., Haghighi K., Marreez Y., Odley A., Dorn G.W., et al. Increased particulate partitioning of PKC epsilon reverses susceptibility of phospholamban knockout hearts to ischemic injury. J Mol Cell Cardiol 2004, 36:313-318.
41. Inagaki K., Begley R., Ikeno F., Mochly-Rosen D. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation 2005, 111:44-50.
42. Churchill E.N., Mochly-Rosen D. The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans 2007, 35:1040-1042.
43. Panaretakis T., Laane E., Pokrovskaja K., Bjorklund A.C., Moustakas A., Zhivotovsky B., et al. Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis. Mol Biol Cell 2005, 16:3821-3831.
44. Shizukuda Y., Buttrick P.M. Subtype specific roles of beta-adrenergic receptors in apoptosis of adult rat ventricular myocytes. J Mol Cell Cardiol 2002, 34:823-831.
45. Ichihara S., Yamada Y., Kawai Y., Osawa T., Furuhashi K., Duan Z., et al. Roles of oxidative stress and Akt signaling in doxorubicin cardiotoxicity. Biochem Biophys Res Commun 2007, 359:27-33.
46. Deres P., Halmosi R., Toth A., Kovacs K., Palfi A., Habon T., et al. Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound. J Cardiovasc Pharmacol 2005, 45:36-43.
47. Ballou L.M., Cross M.E., Huang S., McReynolds E.M., Zhang B.X., Lin R.Z. Differential regulation of the phosphatidylinositol 3-kinase/Akt and p70 S6 kinase pathways by the alpha(1A)-adrenergic receptor in rat-1 fibroblasts. J Biol Chem 2000, 275:4803-4809.
48. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004, 287:C817-C833.
49. Devic E., Xiang Y., Gould D., Kobilka B. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice. Mol Pharmacol 2001, 60:577-583.
50. Kuschel M., Zhou Y.Y., Cheng H., Zhang S.J., Chen Y., Lakatta E.G., et al. G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling. J Biol Chem 1999, 274:22048-22052.
51. Lim M.L., Minamikawa T., Nagley P. The protonophore CCCP induces mitochondrial permeability transition without cytochrome c release in human osteosarcoma cells. FEBS Lett 2001, 503:69-74.
52. Wallace D.C. Mitochondria and cancer: Warburg addressed. Cold Spring Harb Symp Quant Biol 2005, 70:363-374.
53. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004, 113:1535-1549.
54. Ahmet I., Krawczyk M., Zhu W., Woo A.Y., Morrell C., Poosala S., et al. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction. J Pharmacol Exp Ther 2008, 325:491-499.